Provided by Tiger Fintech (Singapore) Pte. Ltd.

Biogen

115.77
-2.8450-2.40%
Volume:645.95K
Turnover:75.55M
Market Cap:16.95B
PE:10.35
High:118.61
Open:117.97
Low:115.45
Close:118.61
Loading ...

Biogen Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
18 Apr

Biogen Unlikely to Receive Boost from Leqembi Approval in EU -- Market Talk

Dow Jones
·
17 Apr

Drug to Treat Underlying Causes of Alzheimer's Gets EU Marketing Approval

Dow Jones
·
16 Apr

Biogen Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
16 Apr

Biogen reports EC grants marketing authorization for Leqembi

TIPRANKS
·
16 Apr

Biogen, Eisai's Alzheimer's Drug Leqembi Approved in EU

MT Newswires Live
·
16 Apr

EU authorizes Eisai-Biogen's drug for treatment of early Alzheimer's disease

Reuters
·
15 Apr

Goldman Sachs Adjusts Biogen's Price Target to $219 From $245, Keeps Buy Rating

MT Newswires Live
·
15 Apr

Biogen Inc. Stock Climbs 3.6%, Outperforms Competitors

Dow Jones
·
15 Apr

BUZZ-Potential EU approval for Biogen's Alzheimer's drug underway; shares rise

Reuters
·
14 Apr

Biogen (BIIB) Receives a Hold from Jefferies

TIPRANKS
·
14 Apr

Biogen - Final Process for Ec Decision on Lecanemab’s Marketing Authorisation Application Underway

THOMSON REUTERS
·
14 Apr

Goldman Sachs Cuts Price Target on Biogen to $219 From $245

MT Newswires Live
·
14 Apr

Pharma Tariffs Are Coming. Investors Underestimate the Risk. -- Barrons.com

Dow Jones
·
12 Apr

Citigroup Adjusts Price Target on Biogen to $125 From $145, Keeps Neutral Rating

MT Newswires Live
·
11 Apr

Biogen price target lowered to $165 from $168 at Guggenheim

TIPRANKS
·
10 Apr

Biogen : Guggenheim Cuts Target Price to $165.00 From $168.00

THOMSON REUTERS
·
10 Apr

Biogen Inc. Stock Rises Wednesday, Still Underperforms Market

Dow Jones
·
10 Apr

Major Pharma Stocks Down Amid Tariff Turmoil

MT Newswires Live
·
09 Apr

Morgan Stanley Adjusts Price Target on Biogen to $152 From $157, Keeps Equalweight Rating

MT Newswires Live
·
09 Apr